Hemolytic Transfusion Reaction

    loading  Checking for direct PDF access through Ovid


To the editor: The recent case report by In wood and Zuliani (1) represents an interesting, and obviously quite rare, occurrence that apparently has prompted the authors to make a misleading, and potentially dangerous, suggestion. On the basis of mild intravascular hemolysis that developed in their patient as a result of the transfusion with extremely high-titered anti-A present in the residual plasma accompanying a unit of group O erythrocytes they suggest “that if this complication is to be avoided, the clinician must rigidly accept the principle that only ABO homologous blood should be transfused to patients.” Considering the nationwide chronic

Related Topics

    loading  Loading Related Articles